End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
101,600 KRW | -0.39% | 0.00% | +0.59% |
Business Summary
Number of employees: 5,530
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Over-the-counter Drugs and Quasi-drugs
55.7
%
| 543,014 | 53.5 % | 631,026 | 55.7 % | +16.21% |
Logistics
31.4
%
| 345,326 | 34.0 % | 355,913 | 31.4 % | +3.07% |
Elimination of Internal Transactions
-21.2
%
| -179,208 | -17.7 % | -239,812 | -21.2 % | +33.82% |
Other
15.1
%
| 118,506 | 11.7 % | 170,770 | 15.1 % | +44.10% |
Packaging Container
9.2
%
| 105,150 | 10.4 % | 104,275 | 9.2 % | -0.83% |
Holding Company
5.2
%
| 54,207 | 5.3 % | 58,383 | 5.2 % | +7.70% |
Biosimilars and Consignment Drugs
4.5
%
| 27,865 | 2.7 % | 51,447 | 4.5 % | +84.63% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 1,014,861 | 100.0 % | 1,132,003 | 100.0 % | +11.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Hyun Han
CEO | Chief Executive Officer | 56 | - |
Seong-Geun Park
DFI | Director of Finance/CFO | 56 | - |
Seong-Yeon Jeong
CMP | Compliance Officer | 42 | - |
Min-Young Kim
BRD | Director/Board Member | 52 | - |
Soo-Jeong Park
PRN | Corporate Officer/Principal | 56 | - |
Jung-Seok Kang
PRN | Corporate Officer/Principal | 59 | 95-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jung-Seok Kang
PRN | Corporate Officer/Principal | 59 | 95-12-31 |
Dong-Cheol Kim
BRD | Director/Board Member | 50 | - |
Jong-Hyun Han
CEO | Chief Executive Officer | 56 | - |
Han-Sang Lee
BRD | Director/Board Member | 53 | - |
Min-Young Kim
BRD | Director/Board Member | 52 | - |
Seong-Geun Park
DFI | Director of Finance/CFO | 56 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,348,913 | 3,224,170 ( 50.78 %) | 98,190 ( 1.547 %) | 50.78 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ST PHARM CO.,LTD. 32.20% | 6,096,552 | 32.20% | 411,994,742 $ |
DONG-A ST CO., LTD. 26.90% | 2,377,047 | 26.90% | 116,263,936 $ |
98,190 | 1.55% | 7,850,369 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.59% | 463M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- A000640 Stock
- Company Dong-A Socio Holdings Co., Ltd.